October 22nd, 2023: OUR XELJANZ LAWYERS ARE CURRENTLY REVIEWING CLAIMS OF INDIVIDUALS WHO HAVE SUFFERED SERIOUS INJURIES INCLUDING LIFE-THREATENING BLOOD CLOTS OR DEATH AFTER TAKING XELJANZ
Have You Suffered Serious Side Effects After Taking Xeljanz?
YOU MAY BE ENTITLED TO FINANCIAL COMPENSATION. COMPLETE THE FORM BELOW FOR A FREE CASE EVALUATION.
October 22nd, 2023: OUR XELJANZ LAWYERS ARE CURRENTLY REVIEWING CLAIMS OF INDIVIDUALS WHO HAVE SUFFERED SERIOUS INJURIES INCLUDING LIFE-THREATENING BLOOD CLOTS OR DEATH AFTER TAKING XELJANZ
Have you suffered severe side effects after taking Xeljanz? Recently, Xeljanz lawyers have pursued allegations that Pfizer negligently designed and produced the drug Xeljanz (tofacitinib) on behalf former users of the top selling drug. Additionally, claims have been filed that Pfizer failed to adequately warn their uses about the risks and potential side effects of taking Xeljanz in their drug safety communication and thereby knowingly put patients in the dark and at risk of adverse events including chest pain, heart attacks, and cardiovascular events.
Who is eligible to file a Xeljanz lawsuit?
Contact the Xejanz attorneys at Marin and Barrett, Inc. immediately if you or a loved one took Xeljanz or Xeljanz XR and suffered serious complications, including any of the following medical problems:
Pulmonary embolism
Deep vein thrombosis
Infections, including fungal infections and tuberculosis, which can be deadly
Lymphoma
Skin Cancer
Diverticulitis and stomach ulcers
Severe allergic reactions
Liver Damage
Our Xeljanz lawyers are available 24/7 to take your call and review your eligibility for possible inclusion in the Xeljanz lawsuits as part of our free consultation. Contact the dangerous drug lawyers at Marin and Barrett, Inc. today to file a Xeljanz/Xeljanz XR claim to recover financial compensation.
WHAT IS XELJANZ (TOFACITINIB)?
Developed and introduced by the drug maker Pfizer, Xeljanz (tofacitinib) was approved by the United States Food and Drug Administration (FDA) in 2012 to treat active rheumatoid arthritis patients, psoriatic arthritis patients, ulcerative colitis patients, and polyarticular course juvenile idiopathic arthritis patients. Since hitting the market Xeljanz has been a massive success for the pharmaceutical company Pfizer; distributed in over 80 countries worldwide and prescribed to almost 200,000 patients for the treatment of rheumatoid arthritis patients in the United States, Xeljanz is responsible for billions of dollars in sales, including $1.8 billion in sales in 2018 alone.
Xeljanz works by acting as a Janus Kinase (JAK) inhibitor that disrupts pathways within the cells that causes inflammatory conditions and decreases activity in the immune system that leads to pain and discomfort associated with rheumatoid arthritis. Available by prescription only to treat patients with rheumatoid arthritis, Xeljanz is administered orally in 5, 10, 11, and 22 milligram tablet dose of tofacitinib; it is also available in an extended-release tablet known as Xeljanx XR.
Despite the popularity of the drug with rheumatoid arthritis patients, a recent safety clinical study and a clinical trial have revealed a heightened risk of blood clots in patients, as well as an increased risk certain types of cancer, a risk of lymphoma, other serious infections and even death for patients taking a high daily dose of tofacitinib. In fact, the health risks were so significant in the post-marketing safety study that in 2019 the FDA issued what is known as a Black Box warning, which is the most stringent of all warning labels and is limited to drugs or devices that carry the most serious risk of death or serious side effects.
If you or a loved one have been adversely affected after taking Xeljanz, call the Xeljanz Attorneys at Marin and Barrett, Inc. today at (888) 348-2735 for a free, no obligation consultation. Our legal team can help with your Xeljanz lawsuit.
XELJANZ 2019 FDA BLACK BOX WARNING: WHAT DO YOU NEED TO KNOW?
In July of 2019 the FDA approved and mandated a Black Box warning for Xeljanz after safety clinical trials found a heightened risk of blood clots and death among patients taking a higher daily dose. In fact, between 2013 and 2018 the FDA received reports of patients taking Xeljanz suffering deep vein thrombosis (DVT) and pulmonary embolisms (PE). In addition to the blood clot risks posed by patients taking Xeljanz, the required warnings also alert patients and healthcare professionals to a host of other issues, including:
Infections, including fungal infections and tuberculosis, which can be deadly
Lymphoma
Skin Cancer
Diverticulitis and stomach ulcers
Severe allergic reactions
Liver Damage
Heart Attack, High Blood Pressure other Cardiovascular Event
Risk of Cancer (Lung Cancer, Breast Cancer, Prostate Cancer, Pancreatic Cancer, Colon Cancer)
Increased Cardiovascular Risk Factor: Cardiovascular Events including cardiac arrest, arterial thrombosis, myocardial infarction, congestive heart failure, and cardiovascular death
While all of these potential side effects are alarming, of particular concern are the pulmonary embolisms, which occur when blood clots travel through the body and reach the lungs. This can result in chest pains, difficulty breathing, coughing up blood, lightheadedness, cardiac events such as cardiac arrest and rapid or irregular heard beat. Other symptoms of a blood clot can include, but aren’t limited to: chest pain that worsens with breathing; sudden shortness of breath; swelling in the arms or legs; red or discolored skin in the arms or legs; leg pain or tenderness. Pulmonary embolisms can be life threatening and require immediate medical attention. In fact, of the patients who reported blood clots as a result of using Xeljanz, fifteen died of their injuries.
If you or a loved one has suffered due to your use of the arthritis drug Xeljanz developed and sold by Pfizer, call the Xeljanz lawsuit attorneys at Marin and Barrett, Inc. today to discuss your case and obtain a free consultation.
If you or a loved one developed an infection, including fungal infections or tuberculosis, lymphoma, skin cancer, diverticulitis, liver damage, deep vein thrombosis, pulmonary embolism or non-melanoma skin cancer, after using the prescription medication Xeljanz or Xeljanz XR you may be entitled to financial compensation. Call the Xeljanz lawyers at Marin and Barrett, Inc. today at (888) 348-2735 to discuss your legal options. The call and consultation are free and confidential.
CAN A XELJANZ ATTORNEY HELP ME WITH A LEGAL CLAIM AGAINST XELJANZ AND PFIZER IF I HAVE SUFFERED SERIOUS MEDICAL PROBLEMS?
If you or a loved one developed an infection, including fungal infections or tuberculosis, lymphoma, skin cancer, diverticulitis, liver damage, deep vein thrombosis or a pulmonary embolism after taking Xeljanz or Xeljanz XR you may have a claim. You may be entitled to financial compensation for damages, including:
Past, present, and future medical expenses
Lost wages and lost earning potential
Pain and suffering
Loss of consortium
Punitive damages, if appropriate
In the tragic event that a loved one as died as a result of their use of Xeljanz or Xeljanz XR, you may be eligible to file a wrongful death claim. Of course there is no amount of money that can bring them back or fill the void left by their absence, but a claim may cover funeral and burial expenses, pain and suffering, and any past expenses incurred as a result of their illness.
XELJANZ LAWSUITS 2023 UPDATE
Attorneys around the country have starting filing lawsuits against Pfizer related to Xeljanz. The claims include allegations that Xeljanz has a design defect, which is to say that Pfizer negligently designed and produced the drug leaving patients vulnerable to potentially devastating side effects. Another claim is that Pfizer failed to adequately warn the public about the risks and potential side effects of taking Xeljanz and that as a result of this failure to warn patients were unknowingly at risk. At the heart of these claims is the fact that the drug only required a warning as recently as July 2019, despite being on the market and available to the public since 2012. That means that there was a nearly seven-year period of patients taking Xeljanz without being adequately informed of the serious risks associated with the drug.
While the U.S. Food and Drug Administration now requires Pfizer to issue warnings and drug safety communications regarding the potential risks to patients taking the medication, Xeljanz is still widely available to patients seeking relief from rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. The drug is still the same and so are the risks, and with so much money on the line it is unlikely that Pfizer is going to remove Xeljanz from the market anytime soon. If you or a loved one has become injured, ill, or suffered blood clot complications using Xeljanz or Xeljanz XR, do not hesitate, call the Xeljanz lawsuit attorneys at Marin and Barrett, Inc. at (888) 348-2735 today, the consultation is confidential and of absolutely no cost to you.
TOP RATED XELJANZ LAWYER
The Pharmaceutical Industry is an international financial powerhouse, spending $1.2 trillion worldwide and $485 billion in the United States alone in 2018. Do not go it alone, let us fight them for you to get the compensation you rightfully deserve. We work hand in hand with some of the most experienced and respected law firms nationwide and have the resources your case needs to stand toe to toe with pharmaceutical giants like Pfizer.
At Marin and Barrett, Inc. we firmly believe that the client’s needs come above all else and have established a fully transparent fee structure to reflect that for our work on our clients defective drugs claims. We work on a strictly contingency fee basis, meaning that we do not receive anything from you unless we are able to recover money either by settlement or verdict. Regardless of what type of case you have or what is required, you will know everything up front with no surprises. We shoulder the costs of the filing and litigation on your behalf and at no risk to you.
Call our Xeljanz attorneys at the defective drug law firm Marin and Barrett, Inc. today (888) 348-2735 to schedule your free consultation if you have suffered a blood clot injury or other dangerous side effects, it only takes a few moments and there is no obligation. Let our personal injury lawyers help you hold the pharmaceutical drug companies and drug manufacturers responsible for your injuries and medical bills.
ATTORNEY MATTHEW MARIN
Admitted in Rhode Island, Connecticut, Massachusetts and South Carolina and Assisting clients as a Rhode Island Xeljanz Lawyer, Connecticut Xeljanz Lawyer, and a Massachusetts Xeljanz Lawyer
ATTORNEY KENSLEY BARETT
Admitted in Rhode Island and Assisting clients as a Rhode Island Xeljanz Lawyer
ATTORNEY NICHOLAS PARRILLO
Admitted in Rhode Island and Massachusetts and Assisting clients as a Rhode Island Xeljanz Lawyer and a Massachusetts Xeljanz Lawyer
XELJANZ DISCLAIMER: Do not stop taking a prescribed medication without first consulting with your doctor. Discontinuing a prescribed medication without your doctor’s advice can result in injury or death.
